9 resultados
The present invention relates to the use of modified oligo-.beta.-(1,3)-glucans of formula (I) or (II) below for the preparation of medicaments which are useful in treatments based on the stimulation of the immune system.
The glucans, which are natural products, have long been studied and the
TECHNICAL FIELD
The present invention relates to the field of biomedicine, and relates specifically to the use of fructose analogs and the combination of fructose analogs and glucose analogs in the treatment of cancer and organ fibrosis.
BACKGROUND
It is well known that the occurrence and
TECHNICAL FIELD
The present invention is directed to lyophilized pharmaceutical preparations comprising cytotoxic dipeptides or pharmaceutically acceptable salts thereof, methods for their preparation, compositions comprising the lyophilized pharmaceutical preparations and their use in the treatment
TECHNICAL FIELD
The present invention is directed to lyophilized pharmaceutical preparations comprising cytotoxic dipeptides or pharmaceutically acceptable salts thereof, methods for their preparation, compositions comprising the lyophilized pharmaceutical preparations and their use in the treatment
FIELD OF THE INVENTION
This invention relates to stable formulations of viruses and virus-based vaccines. A difficulty in stabilizing viruses at temperatures below the freezing point of water is preventing the physical disruption of structural and functional components during freezing and thawing.
FIELD OF THE INVENTION
This invention relates to stable formulations of viruses and virus-based vaccines. A difficulty in stabilizing viruses at temperatures below the freezing point of water is preventing the physical disruption of structural and functional components during freezing and thawing.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to non-effervescent, solid dosage forms adapted for oral administration of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carb- azol-4-one (ondansetron) as an anti-emetic active
The invention relates to new hexitols having the formulae (I) and (II), ##STR3## wherein the hexitol skeleton is dulcitol, mannitol or iditol,
X represents halogen, preferably bromine,
R is a saturated or unsaturated C.sub.4-10 alkylcarbonyl group which also contains a free carboxy group,
FIELD OF THE INVENTION
This invention relates to lyophilized aqueous parenteral solutions of antitumor agents. More particularly, this invention relates to lyophilized aqueous thioxanthenone antitumor agents.
Reported Developments
Many conventional drug substances and proteins destined for